* Kodiak Sciences Inc KOD.OQ KOD.O is expected to show
no
change in quarterly revenue when it reports results on May 13
(estimated) for the period ending March 31 2024
*
* LSEG's mean analyst estimate for Kodiak Sciences Inc is
for a
loss of $1.07 per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 3 "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 4.9%
in the last three months.
* Wall Street's median 12-month price target for Kodiak
Sciences
Inc is $4.00, above its last closing price of $3.61.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.68 -0.77 -1.13 Missed -46.1
Sep. 30 2023 -1.31 -1.21 -0.95 Beat 21.3
Jun. 30 2023 -1.00 -1.14 -1.53 Missed -34.1
Mar. 31 2023 -1.21 -1.33 -1.35 Missed -1.8
Dec. -1.53 -1.35 Beat 11.5
31 2022
Sep. 30 2022 -1.77 -1.77 -1.47 Beat 16.9
Jun. 30 2022 -1.76 -1.76 -1.74 Beat 0.9
Mar. 31 2022 -1.57 -1.54 -1.83 Missed -19
This summary was machine generated May 10 at 22:44 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)